Echogenicity of the substantia nigra: Association with increased iron content and marker for susceptibility to nigrostriatal injury

Archives of Neurology

Volumn 59, Issue 6, 2002, Pages 999-1005

  Berg, Daniela ^a   Roggendorf, Wolfgang ^a   Schröder, Ute ^b   Klein, Rüdiger ^a   Tatschner, Thomas ^a   Benz, Peter ^d   Tucha, Oliver ^c   Preier, Michael ^c   Lange, Klaus W ^c   Reiners, Karlheinz ^a   Gerlach, Manfred ^a   Becker, Georg ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FLUORINE 18; IRON;

ARTICLE; AUTOPSY; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DISEASE MARKER; DISEASE PREDISPOSITION; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; EXTRAPYRAMIDAL SYNDROME; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON STORAGE; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0036279410     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.6.999     Document Type: Article

References (31)

1. Pargyline prevents MPTP-induced parkinsonism in primates
2. Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations
3. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
4. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial colorcoded real-time sonography
5. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
6. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia
7. Altered brain metabolism of iron as a cause of neurodegenerative diseases?
8. Rate of cell death in parkinsonism indicates active neuropathological process
9. Iron accumulation of the substantia nigra in rats visualized by ultrasound
10. Statements from the Vancouver Group
11. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
12. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205
13. α-Synuclein and Lewy bodies
14. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
15. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism
16. Prospects for new restorative and neuroprotective treatments in Parkinson's disease
17. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
18. The neurotoxicity of iron and nitric oxide: Relevance to the etiology of Parkinson's disease
19. Iron in the Parkinsonian substantia nigra
20. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
21. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
22. Ageing and Parkinson's disease: Substantia nigra regional selectivity
23. Pathology of Parkinson's disease
24. Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): Relationship to parkinsonism
25. The genetics of Parkinson's disease: A reconsideration
26. Endogenous toxins as potential etiologic agents in Parkinson's disease
27. Environmental agents and Parkinson's disease
28. Relationship of substantia nigra echogenicity and motor function in elderly subjects